Labcorp (LH)
(Delayed Data from NYSE)
$216.00 USD
+0.93 (0.43%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $216.01 +0.01 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value B Growth F Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$216.00 USD
+0.93 (0.43%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $216.01 +0.01 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value B Growth F Momentum B VGM
Zacks News
Is Laboratory Corporation of America Holdings (LH) Outperforming Other Medical Stocks This Year?
by Zacks Equity Research
Is (LH) Outperforming Other Medical Stocks This Year?
SmileDirectClub (SDC) in Focus: Stock Moves 5.8% Higher
by Zacks Equity Research
SmileDirectClub (SDC) saw a big move last session, as its shares jumped nearly 6% on the day, amid huge volumes.
Top Ranked Growth Stocks to Buy for November 17th
by Zacks Equity Research
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, November 17th.
LH or CNMD: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
LH vs. CNMD: Which Stock Is the Better Value Option?
Amedisys (AMED) Banks on Home Health & Hospice Amid Cost Woe
by Zacks Equity Research
Amedisys (AMED) continues to benefit from the recent acquisitions of hospice care providers.
QIAGEN (QGEN) Launches COVID-19 Antigen Test With Ellume
by Zacks Equity Research
QIAGEN (QGEN) starts commercializing latest test after filing for FDA emergency use authorization (EUA) for symptomatic patients.
Zacks.com featured highlights include: Molson Coors Beverage, Whirlpool, Snap-on, Kroger and Laboratory Corporation of America
by Zacks Equity Research
Zacks.com featured highlights include: Molson Coors Beverage, Whirlpool, Snap-on, Kroger and Laboratory Corporation of America
Top Ranked Growth Stocks to Buy for November 13th
by Zacks Equity Research
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, November 13th
5 Excellent PEG Stocks for GARP Investors
by Urmimala Biswas
PEG-based investing can turn out to be even more rewarding if some other relevant parameters are also taken into consideration.
Is LabCorp (LH) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Zacks.com featured highlights include: Canadian Solar, Laboratory Corporation of America, Boise Cascade, Atlas Corp and Pampa Energia
by Zacks Equity Research
Zacks.com featured highlights include: Canadian Solar, Laboratory Corporation of America, Boise Cascade, Atlas Corp and Pampa Energia
Explore These 5 Momentum Stocks Using Driehaus Strategy
by Nitish Marwah
Investors who have the propensity to take a higher risk can think of investing in momentum stocks to boost their gains.
6 Low Price-to-Book Value Stocks to Tap Market Boom
by Kinjel Shah
When it comes to valuation metrics, though P/E and P/S are the first choices, the P/B ratio is also emerging as a convenient tool to identify low-priced stocks that have high-growth prospects.
Scoop Up These 5 Stocks With Exciting Interest Coverage Ratio
by Sumit Singh
A company that is capable of generating earnings well above its interest expense can withstand financial hardships.
The Zacks Analyst Blog Highlights: Sleep Number, Tempur Sealy, Laboratory Corporation of America and Gerdau
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Sleep Number, Tempur Sealy, Laboratory Corporation of America and Gerdau
LabCorp (LH) Hits 52-Week High, Can the Run Continue?
by Zacks Equity Research
LabCorp (LH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Investing in Growth Remains Solid Strategy: 4 Picks
by Sejuti Banerjea
Investing opportunistically in growth stocks is the way to go in volatile markets.
Canopy Growth (CGC) to Report Q2 Earnings: What's in Store?
by Zacks Equity Research
Continued momentum from robust product demand is expected to have significantly contributed to Canopy Growth's (CGC) top line in fiscal second quarter.
The Zacks Analyst Blog Highlights: FedEx, Whirlpool, The Boston Beer Company, Laboratory Corporation of America and DaVita
by Zacks Equity Research
The Zacks Analyst Blog Highlights: FedEx, Whirlpool, The Boston Beer Company, Laboratory Corporation of America and DaVita
Wall Street Suffers Back-to-Back Monthly Decline: What Next?
by Nalak Das
At this stage, it will be prudent to invest in large-cap growth/momentum stocks like Zoom Video (ZM), FedEx (FDX), Whirlpool (WHR), The Boston Beer (SAM), Laboratory Corp. (LH), RPM Intetnational (RPM), Brown & Brown (BRO) and DaVita (DVA).
Are You Looking for a Top Momentum Pick? Why LabCorp (LH) is a Great Choice
by Zacks Equity Research
Does LabCorp (LH) have what it takes to be a top stock pick for momentum investors? Let's find out.
LH vs. CNMD: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
LH vs. CNMD: Which Stock Is the Better Value Option?
Is Laboratory Corporation of America Holdings (LH) Outperforming Other Medical Stocks This Year?
by Zacks Equity Research
Is (LH) Outperforming Other Medical Stocks This Year?
Merit Medical (MMSI) Soars to 52-Week High, Time to Cash Out?
by Zacks Equity Research
Merit Medical (MMSI) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
New Strong Buy Stocks for October 30th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today.